Labcorp Holdings (LH) Income from Non-Controlling Interests (2009 - 2026)
Labcorp Holdings (LH) posted Income from Non-Controlling Interests of $200000.0 for Q1 2026, little changed sequentially from $200000.0 in Q4 2025, and little changed YoY from $200000.0 in Q1 2025.
Labcorp Holdings (LH) Income from Non-Controlling Interests (2009 - 2026) Analysis & Trends
Labcorp Holdings has reported Income from Non-Controlling Interests for 18 years, with the latest figure at $200000.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests changed 0.0% year-over-year to $200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 20.0% YoY) and the FY2025 annual result came in at $1.2 million, up 9.09% from the prior year.
- Income from Non-Controlling Interests held at $200000.0 in Q1 2026 per LH's latest filing, from $200000.0 in the prior quarter.
- Over five years, Income from Non-Controlling Interests peaked at $500000.0 in Q1 2022 and troughed at $200000.0 in Q2 2023.
- A 5-year average of $305882.4 and a median of $300000.0 in 2022 frame the typical range for Income from Non-Controlling Interests.
- The sharpest annual moves came in 2022 and 2024: Income from Non-Controlling Interests plunged 50.0% in 2022, then soared 50.0% in 2024.
- Over 5 years, Income from Non-Controlling Interests stood at $300000.0 in 2022, then changed by 0.0% to $300000.0 in 2023, then plunged by 33.33% to $200000.0 in 2024, then changed by 0.0% to $200000.0 in 2025, then changed by 0.0% to $200000.0 in 2026.
- According to Business Quant data, Income from Non-Controlling Interests over the past three periods registered $200000.0, $200000.0, and $400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 5.00 Mn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | - |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | - |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | - |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | - |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 400,000.00 |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 14.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 400,000.00 |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 400,000.00 |
| Dec 31, 2022 | 300,000.00 |
| Sep 30, 2022 | 400,000.00 |
| Jun 30, 2022 | 300,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | 600,000.00 |
| Sep 30, 2021 | 500,000.00 |